These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 28549493)

  • 1. The Adverse Effect of the 2-1-1 Regimen for Rabies PEP in Preschool Children.
    Liu SQ; Tao XY; Yu PC; Jin CQ; Yu HJ; Chen MS; Zhu WY
    Biomed Environ Sci; 2017 May; 30(5):373-375. PubMed ID: 28549493
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunogenicity and safety of purified chick-embryo cell rabies vaccine under Zagreb 2-1-1 or 5-dose Essen regimen in Chinese children 6 to 17 years old and adults over 50 years: a randomized open-label study.
    Li R; Li Y; Wen S; Wen H; Nong Y; Mo Z; Xie F; Pellegrini M
    Hum Vaccin Immunother; 2015; 11(2):435-42. PubMed ID: 25692350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative study on the immunogenicity and safety of a purified chick embryo cell rabies vaccine (PCECV) administered according to two different simulated post exposure intramuscular regimens (Zagreb versus Essen).
    Mahendra BJ; Narayana DA; Agarkhedkar S; Ravish HS; Harish BR; Agarkhedkar S; Madhusudana SN; Belludi A; Ahmed K; Jonnalagedda R; Vakil H; Bhusal C; Arora AK
    Hum Vaccin Immunother; 2015; 11(2):428-34. PubMed ID: 25692792
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunogenicity, safety and antibody persistence of a purified vero cell cultured rabies vaccine (Speeda) administered by the Zagreb regimen or Essen regimen in post-exposure subjects.
    Shi N; Zhang Y; Zheng H; Zhu Z; Wang D; Li S; Li Y; Yang L; Zhang J; Bai Y; Lu Q; Zhang Z; Luo F; Yu C; Li L
    Hum Vaccin Immunother; 2017 Jun; 13(6):1-8. PubMed ID: 28121231
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized open-labeled study to demonstrate the non-inferiority of purified chick-embryo cell rabies vaccine administered in the Zagreb regimen (2-1-1) compared with the Essen regimen in Chinese adults.
    Ma J; Wang H; Li J; Chang L; Xie Y; Liu Z; Zhao Y; Malerczyk C
    Hum Vaccin Immunother; 2014; 10(10):2805-12. PubMed ID: 25483635
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunogenicity and safety of purified vero cell rabies vaccine (PVRV) produced by Liaoning Cheng Da Co. under Zagreb 2-1-1 or 5-dose Essen regimen in Chinese adults aged 50 and above.
    Wang J; Luo F; Feng Z; Li L; Bai Y; Ai X; Ma J; Zhang Z; Shi N
    Hum Vaccin Immunother; 2017 Jan; 13(1):144-150. PubMed ID: 28045585
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of safety and immunogenicity of purified chick embryo cell vaccine using Zagreb and Essen regimens in patients with category II exposure in China.
    Hu Q; Liu MQ; Zhu ZG; Zhu ZR; Lu S
    Hum Vaccin Immunother; 2014; 10(6):1645-9. PubMed ID: 24632727
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The immunogenicity and safety of vaccination with purified Vero cell rabies vaccine (PVRV) in China under a 2-1-1 regimen.
    Liu H; Huang G; Tang Q; Li J; Cao S; Fu C; Cao Q; Liu B; Pan H; Wang M
    Hum Vaccin; 2011 Feb; 7(2):220-4. PubMed ID: 21311216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and immunogenicity of human rabies vaccine for the Chinese population after PEP: A systematic review and meta-analysis.
    Wang L; Zhang J; Meng S; Ge L; You Y; Xu Q; Wang H; Yang J; Wang S; Wu H
    Vaccine; 2022 Jul; 40(32):4371-4379. PubMed ID: 35750539
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Post-exposure rabies prophylaxis in humans exposed to animals in Lublin province (Eastern Poland) in 2012-2015 - A retrospective study.
    Krzowska-Firych J; Tomasiewicz K; Kozøowska A
    Hum Vaccin Immunother; 2017 Jun; 13(6):1-6. PubMed ID: 28166482
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adverse events following rabies post-exposure prophylaxis: a comparative study of two different schedules and two vaccines.
    Sari T; Tulek N; Bulut C; Oral B; Tuncer Ertem G
    Travel Med Infect Dis; 2014; 12(6 Pt A):659-66. PubMed ID: 24685372
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human rabies post exposure prophylaxis in Bhutan, 2005-2008: trends and risk factors.
    Tenzin ; Dhand NK; Ward MP
    Vaccine; 2011 May; 29(24):4094-101. PubMed ID: 21497633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rabies postexposure prophylaxis in routine practice in view of the new Centers for Disease Control and Prevention and World Health Organization recommendations.
    Uwanyiligira M; Landry P; Genton B; de Valliere S
    Clin Infect Dis; 2012 Jul; 55(2):201-5. PubMed ID: 22550115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and immunogenicity of rabies vaccine as 4 - dose Essen Intramuscular regimen for post exposure prophylaxis: A non - randomized, comparative controlled study.
    Haradanahalli RS; Banerjee R; Kalappa MS; Narayana A; Annadani RR; Bilagumba G
    Hum Vaccin Immunother; 2021 Aug; 17(8):2554-2559. PubMed ID: 33621471
    [No Abstract]   [Full Text] [Related]  

  • 15. Adverse effects of rabies pre- and postexposure prophylaxis in 290 health-care-workers exposed to a rabies infected organ donor or transplant recipients.
    Mattner F; Bitz F; Goedecke M; Viertel A; Kuhn S; Gastmeier P; Mattner L; Biertz F; Heim A; Henke-Gendo C; Engelmann I; Martens A; Strüber M; Schulz TF
    Infection; 2007 Jun; 35(4):219-24. PubMed ID: 17646909
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rabies post-exposure prophylaxis in Germany - What are the challenges?
    Meyerhoff P; Manekeller S; Saleh N; Boesecke C; Schlabe S; Wasmuth JC; van Bremen K; Eis-Hübinger AM; von Fischer-Treuenfeld J; Menting T; Rockstroh JK; Schwarze-Zander C
    Epidemiol Infect; 2021 Mar; 149():e119. PubMed ID: 33734061
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and immunogenicity of chromatographically purified Vero cell rabies vaccine for intradermal pre- and post-exposure rabies prophylaxis.
    Tantawichien T; Sibunruang S; Tantawichien T; Angsanakul J; Benjavongkulchai M; Limsuwan K; Udomchaisakul P; Khomvilai S; Sitprija V
    Expert Rev Vaccines; 2014 Dec; 13(12):1593-601. PubMed ID: 25315021
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety of post-exposure rabies prophylaxis during pregnancy: a follow-up study from Guangzhou, China.
    Huang G; Liu H; Cao Q; Liu B; Pan H; Fu C
    Hum Vaccin Immunother; 2013 Jan; 9(1):177-83. PubMed ID: 23442589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Real-world evidence of rabies post-exposure prophylaxis in Serbia: Nation-wide observational study (2017-2019).
    Banović P; Mijatović D; Simin V; Vranješ N; Meletis E; Kostoulas P; Obregon D; Cabezas-Cruz A
    Travel Med Infect Dis; 2024; 58():102697. PubMed ID: 38369074
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rabies post-exposure prophylaxis vaccination with purified chick embryo cell vaccine (PCECV) and purified Vero cell rabies vaccine (PVRV) in a four-site intradermal schedule (4-0-2-0-1-1): an immunogenic, cost-effective and practical regimen.
    Ambrozaitis A; Laiskonis A; Balciuniene L; Banzhoff A; Malerczyk C
    Vaccine; 2006 May; 24(19):4116-21. PubMed ID: 16545510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.